Mutant virus: should we be worried that Sars-CoV-2 is changing?
Scientists tracking the virus have uncovered a major mutation, but it may not be as scary as it soundsCoronavirus – latest updatesSee all our coronavirus coverageScientists have had eyes on Sars-CoV-2, the virus that causes Covid-19, since the beginning of this pandemic.They can see it is evolving, but it is happening at a glacial pace compared with two other viruses with pandemic potential: those that cause flu and Aids. That is good news for efforts to develop vaccines and treatments, but scientists remain wary that anything could still happen.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 18, 2020 Category: Science Authors: Laura Spinney Tags: Coronavirus outbreak Infectious diseases Medical research Microbiology Science World news Vaccines and immunisation Health Source Type: news

Flu Vaccination in High - Risk Groups May Reduce CV Events
Hospitalized patients at high risk who are vaccinated have lower rates of MI, TIA, cardiac arrest, death (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - August 7, 2020 Category: Respiratory Medicine Tags: Cardiology, Endocrinology, Family Medicine, Geriatrics, Infections, AIDS, Internal Medicine, Nursing, Pharmacy, Pulmonology, Conference News, Source Type: news

Locking down shape-shifting spike protein aids development of COVID-19 vaccine
The experimental vaccine against SARS-CoV-2 that was the first to enter human trials in the United States has been shown to elicit neutralizing antibodies and a helpful T-cell response with the aid of a carefully engineered spike protein that mimics the infection-spreading part of the virus. (Source: World Pharma News)
Source: World Pharma News - August 5, 2020 Category: Pharmaceuticals Tags: Featured Events Source Type: news

Religion & the Pandemic: A Call Beyond the Here & Now
Religions for Peace Interreligious Council of Albania distributing Covid relief supplies from the Multi-religious Humanitarian Fund. Credit: Erzen CarjaBy Prof. Azza KaramNEW YORK, Aug 4 2020 (IPS) — I have never been interested in religion or spirituality before, but I found myself tuning in to all sorts of on-line religion and spirituality related forums “in search of something.” These are the words of a 30-something single young, middle class man (born into a Protestant-Catholic family background) in a European country. The latter is known more for turning several churches into museums or shopping ce...
Source: IPS Inter Press Service - Health - August 4, 2020 Category: International Medicine & Public Health Authors: Azza Karam Tags: Civil Society Featured Global Headlines Health Human Rights Humanitarian Emergencies Inequity Religion TerraViva United Nations Source Type: news

Dr. Anthony Fauci Expresses ‘Cautious’ Optimism That COVID-19 Vaccine Will Be Available to Americans in 2021
(WASHINGTON) — Once a coronavirus vaccine is approved as safe and effective, Americans should have widespread access within a reasonable time, Dr. Anthony Fauci assured lawmakers Friday. Appearing before a House panel investigating the nation’s response to the pandemic, Fauci expressed “cautious” optimism that a vaccine would be available, particularly by next year. “I believe, ultimately, over a period of time in 2021, that Americans will be able to get it,” Fauci said, referring to the vaccine. There will be a priority list for who gets early vaccinations. “I don’t think we...
Source: TIME: Health - July 31, 2020 Category: Consumer Health News Tags: Uncategorized Congress COVID-19 News Desk wire Source Type: news

Will You Get a COVID-19 Vaccine? Will You Get a COVID-19 Vaccine?
When a COVID-19 vaccine becomes available, will you get it and recommend it to your patients?Medscape Reader Polls (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 28, 2020 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Coronavirus antibodies fall dramatically in first 3 months after mild cases of COVID-19
FINDINGSA study by UCLA researchers shows that in people with mild cases of COVID-19, antibodies against SARS-CoV-2 — the virus that causes the disease — drop sharply over the first three monthsafter infection,decreasing by roughly half every  73 days. If sustained at that rate, the antibodies would disappear within about a year.BACKGROUNDPrevious reports have suggested that antibodies against the novel coronavirus are short-lived, but the rate at which theydecrease has not been carefully defined. This is the first study to carefully estimate the rate at which the antibodies disappear.METHODThe researchers...
Source: UCLA Newsroom: Health Sciences - July 21, 2020 Category: Universities & Medical Training Source Type: news

Fauci:'The Virus Is a Formidable Foe'Fauci:'The Virus Is a Formidable Foe '
Dr Anthony Fauci discusses the COVID-19 pandemic, the US response, and the outlook for a vaccine to combat the virus.WebMD (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 18, 2020 Category: Infectious Diseases Tags: Infectious Diseases Expert Interview Source Type: news

Mumps Cases Disproportionately Affecting Persons Living with HIV Infection and Men Who Have Sex with Men - Chicago, Illinois, 2018
This report describes the use of spatiotemporal analysis to identify clusters of people with mumps and target public health response efforts in Chicago. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - July 16, 2020 Category: American Health Tags: HIV/AIDS HIV/AIDS and STDs Measles, Mumps, Rubella, Varicella (MMRV) Vaccine Safety Men's Health MMWR Morbidity & Mortality Weekly Report Mumps Vaccination Source Type: news

Africa: Global Health Actors Forge a Common Front to Combat COVID-19
[GFO] On 24 April 2020, the Global Fund, the World Health Organization (WHO) and a range of global health actors launched the Access to COVID-19 Tools (ACT) Accelerator, a global collaboration to speed up the development and production of vaccines, diagnostics, and therapeutics for the coronavirus disease 2019 (COVID-19) for all who need them globally. The other global health actors in the partnership include the Bill& Melinda Gates Foundation (BMGF), the Coalition for Epidemic Preparedness Innovations (CEP (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - July 16, 2020 Category: Infectious Diseases Source Type: news

IntraHealth, Frontline Health Workers Coalition Urge US Policymakers to Maintain WHO Ties
July 15, 2020IntraHealth International joins theFrontline Health Workers Coalition in urging US policymakers to restore the US’s affiliation with the World Health Organization (WHO) and to cease moving forward on terminating the relationship.On July 6, the Trump Administration began the year-long process to officially terminate the U.S. relationship with the World Health Organization. This decision threatens global health security and will impede the US and other countries in responding to the COVID-19 pandemic and other critical health needs.“We are strongly opposed to this decision,” saysPolly Dunford, ...
Source: IntraHealth International - July 15, 2020 Category: International Medicine & Public Health Authors: mnathe Tags: COVID-19 Policy & Advocacy Global health security Source Type: news

The Role of Food Handlers in Hepatitis A Virus Transmission The Role of Food Handlers in Hepatitis A Virus Transmission
How significant is the risk of secondary transmission from hepatitis A-infected food handlers to food establishment customers? Is preemptive vaccination of food handlers warranted?Morbidity & Mortality Weekly Report (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 15, 2020 Category: Infectious Diseases Tags: Public Health & Prevention Journal Article Source Type: news

Brazilian AIDS Patient Shows No Sign of Virus After Experimental Drug Therapy
A Brazilian man infected with the AIDS virus has shown no sign of it for more than a year since he stopped HIV medicines after an intense experimental drug therapy aimed at purging hidden, dormant virus from his body, doctors reported Tuesday. The case needs independent verification and it’s way too soon to speculate about a possible cure, scientists cautioned. “These are exciting findings but they’re very preliminary,” said Dr. Monica Gandhi, an AIDS specialist at the University of California, San Francisco. “This has happened to one person, and one person only,” and it didn’t suc...
Source: TIME: Health - July 7, 2020 Category: Consumer Health News Authors: Marilynn Marchione / AP Tags: Uncategorized HIV/AIDS News Desk wire Source Type: news

Trump is scooping up the world ’s remdesivir. It’s a sign of things to come | Devi Sridhar
The case of the Covid-19 drug shows how national interests will continue to define the allocation of research productsCoronavirus – latest updatesSee all our coronavirus coverageDonald Trump has calledCovid-19 a hoax, encouraged his followers to takehydroxychloroquine and threatened to cut all ties between the US and theWorld Health Organization. He has predicted that coronavirus will disappear one day, likea miracle, organised indoor rallies with no masks during the height of the pandemic and encouraged public health officials toslow down testing, because carrying out tests results in a larger number of confirmed ca...
Source: Guardian Unlimited Science - July 4, 2020 Category: Science Authors: Devi Sridhar Tags: Coronavirus outbreak Infectious diseases World news Medical research US politics Donald Trump Microbiology Science Source Type: news

Study: New Form Of Coronavirus Spreads Faster, But Doesn ’ t Make People Sicker
(CNN) — A global study has found strong evidence that a new form of the coronavirus has spread from Europe to the US. The new mutation makes the virus more likely to infect people but does not seem to make them any sicker than earlier variations of the virus, an international team of researchers reported Thursday. “It is now the dominant form infecting people,” Erica Ollmann Saphire of the La Jolla Institute for Immunology and the Coronavirus Immunotherapy Consortium, who worked on the study, told CNN. “This is now the virus.” The study, published in the journal Cell, builds on some earlier wo...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 3, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston CNN Coronavirus Source Type: news

Africa: Africa Waited for Solutions to Past Health Crises - Will It Be Different for COVID-19?
[The Conversation Africa] The World Health Organisation (WHO) recently noted that "researchers are working at break-neck speed" to understand SARS-CoV-2, the virus that causes coronavirus disease (COVID-19). They are also working to develop potential vaccines, medicines and other technologies that are affordable and equitable. By June 2020 - six months since it was first identified - thousands of therapeutic trials and dozens of vaccine development studies were under way, including one vaccine study each in South Africa and Nigeria (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - July 3, 2020 Category: Infectious Diseases Source Type: news

Fact Check: Trump Praises Scientists for Coming Up With an AIDS Vaccine That Does Not Exist
(WASHINGTON) — Seizing on a medical milestone that doesn’t exist, President Donald Trump said Tuesday he thinks the same scientific expertise that produced a vaccine for AIDS can deliver one soon for COVID-19, too. There is no vaccine for AIDS. Trump also accused the previous administration of making no effort to stop abusive policing, ignoring a conspicuous drive by President Barack Obama to do just that. Trump addressed policing and the pandemic in remarks at the White House for the signing of an executive order encouraging better law enforcement practices. A day earlier, his vice president mischaracterized t...
Source: TIME: Health - June 17, 2020 Category: Consumer Health News Authors: CALVIN WOODWARD and HOPE YEN / AP Tags: Uncategorized News Desk Vaccines wire Source Type: news

Trump Mentions AIDS Vaccine That Does Not Exist, Predicts Covid-19 Vaccine By End Of 2020
U.S. President Donald Trump said, “They’ve come up with the AIDS vaccine.” There's one major problem with that statement. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 17, 2020 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Business /business Policy /policy Editors' Pick editors-pick pharma Source Type: news

The Curious Case of Covid-19 in Africa
Eunice G. Kamwendo is an Economist and Strategic Advisor with UNDP Africa in New York. Chaltu Daniel Kalbessa is a UNDP Fellow and Strategic Analyst with UNDP Africa in New York.By Eunice G. Kamwendo and Chaltu Daniel KalbessaNEW YORK, Jun 3 2020 (IPS) With very weak health systems and overall capacity constraints to effectively respond to the deadly coronavirus disease, Africa’s fate against the invisible enemy, was going to be nothing short of catastrophic according to early predictions. Although Africa is yet to reach its peak, many countries are not seeing the exponential growth in case numbers, or in mortality r...
Source: IPS Inter Press Service - Health - June 3, 2020 Category: International Medicine & Public Health Authors: Eunice G. Kamwendo and Chaltu Daniel Kalbessa Tags: Africa Aid Headlines Health Humanitarian Emergencies TerraViva United Nations Source Type: news

Why Don't We Have a Vaccine for SARS or MERS? Why Don't We Have a Vaccine for SARS or MERS?
We don't have vaccines for SARS, MERS, or HIV. Does that spell doom for efforts to develop a vaccine for SARS-CoV-2?Medscape Internal Medicine (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - May 28, 2020 Category: Infectious Diseases Tags: Internal Medicine Commentary Source Type: news

Merck Leaps Into COVID-19 Development Fray With Vaccine, Drug Deals Merck Leaps Into COVID-19 Development Fray With Vaccine, Drug Deals
Merck, which has largely kept to the sidelines of the race for COVID-19 treatments, said it was buying Austrian vaccine maker Themis Bioscience and would collaborate with research nonprofit IAVI to develop two separate vaccines.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - May 27, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

Merck to buy Austrian vaccine maker as it jumps into COVID-19 race
Merck& Co Inc , which has largely kept to the sidelines of the race for COVID-19 treatments, said it was buying Austrian vaccine maker Themis Bioscience and would collaborate with research nonprofit IAVI to develop two separate vaccines. (Source: Reuters: Health)
Source: Reuters: Health - May 26, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Merck makes big push into Covid-19 arena with three new deals, including one with Miami biotech
Merck& Co. expanded its efforts to prevent and treat Covid-19 in a big way Tuesday with three deals aimed at developing both vaccines and therapies for the new strain of the coronavirus. In one deal, Merck (NYSE: MRK) said it has reached an agreement to acquire Themis Bioscience, an Austrian vaccine developer. Merck also announced a Covid-19 vaccine collaboration with IAVI, a nonprofit organization, and a partnership with Miami-based Ridgeback Biotherapeutics to develop Covid-19 therapies. Dr.… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 26, 2020 Category: Biotechnology Authors: John George Source Type: news

Merck makes big push into Covid-19 arena with three new deals
Merck& Co. expanded its efforts to prevent and treat Covid-19 in a big way Tuesday with three deals aimed at developing both vaccines and therapies for the new strain of the coronavirus. In one deal, Merck (NYSE: MRK) said it has reached an agreement to acquire Themis Bioscience, an Austrian vaccine developer. Merck also announced a Covid-19 vaccine collaboration with IAVI, a nonprofit organization, and a partnership with Ridgeback Biotherapeutics to develop Covid-19 therapies. Dr. Roger M. Perlmutter,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 26, 2020 Category: Biotechnology Authors: John George Source Type: news

Politics, Profits Undermine Public Interest in Covid-19 Vaccine Race
By Anis Chowdhury and Jomo Kwame SundaramSYDNEY and KUALA LUMPUR, May 26 2020 (IPS) With well over five million Covid-19 infections worldwide, and deaths exceeding 340,000, the race for an effective vaccine has accelerated since the SARS-Cov-2 virus was first identified as the culprit. Expecting to score politically from being ‘first’ to have a vaccine, US President Trump’s Operation Warp Speed promises to get 300 million doses to Americans by January, after the November polls, following several failed attempts to monopolize vaccines being developed by European companies. Anis Chowdhury More than 115 vac...
Source: IPS Inter Press Service - Health - May 26, 2020 Category: International Medicine & Public Health Authors: Anis Chowdhury and Jomo Kwame Sundaram Tags: Aid Economy & Trade Featured Global Headlines Health Humanitarian Emergencies TerraViva United Nations Jomo Kwame Sundaram & Anis Chowdhury Source Type: news

Everyone wants to 'follow the science'. But we can't waste time on blame
The Royal Society president says scientists must not be made scapegoats for policy failuresCoronavirus – latest updatesSee all our coronavirus coverageIn 1981, a virus that had jumped the species barrier some decades earlier to infect humans began to wreak havoc among the gay community in San Francisco and New York. A taskforce was set up to study the cause of this disease, and it took a few years to identify HIV as the definitive cause of Aids and its genome to be sequenced, and nearly 15 years before a cocktail of drugs meant that having an HIV infection was no longer a certain death sentence.Forty years later, the...
Source: Guardian Unlimited Science - May 24, 2020 Category: Science Authors: Venki Ramakrishnan Tags: Coronavirus outbreak Medical research Health policy Vaccines and immunisation Politics Science Infectious diseases Aids and HIV Source Type: news

Long-acting drug acts like a short-term AIDS vaccine
(Source: ScienceNOW)
Source: ScienceNOW - May 21, 2020 Category: Science Authors: Cohen, J. Tags: Medicine, Diseases In Depth Source Type: news

Presidents and prime ministers lead call for ‘people’s vaccine’, free to all
UNAIDS, the UN agency fighting against the deadly HIV/AIDS virus, has initiated a petition from global leaders requesting that when a successful COVID-19 vaccine is developed, it be made available free of charge to all. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - May 14, 2020 Category: International Medicine & Public Health Source Type: news

Covid-19 crisis raises hopes of end to UK transmission of HIV
Sexual health experts see in lockdown restrictions a ‘once-in-a-lifetime’ chanceCoronavirus – latest updatesSee all our coronavirus coverage“In the war against any infectious virus,” says Dr Alan McOwan, “You’re trying to win various battles. You have to keep clobbering it from every direction you can.”That ’s true for coronavirus, he says, as well as for other viral conditions. An HIV specialist at London’s 56 Dean Street sexual health clinic, McOwan sees similarities between Covid-19 and HIV. Both are viruses without a working vaccine, you can be infectious with...
Source: Guardian Unlimited Science - May 13, 2020 Category: Science Authors: Michael Segalov Tags: Aids and HIV Society Health Coronavirus outbreak Science Infectious diseases UK news Source Type: news

Demand for coronavirus tests raises concerns over HIV and malaria
Some firms shifting production away from malaria, HIV and TB, which kill millionsCoronavirus – latest updatesSee all our coronavirus coverageGovernments were caught out when Covid-19 hit, having overlooked the need to be able to test for new diseases because they were focused on drugs and vaccines for those they already knew about.Now there are fears that the rush to supply wealthier countries pressing for more tests may destabilise the fight against HIV, malaria and tuberculosis, illnesses that kill millions, mostly in low- and middle-income countries.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - May 1, 2020 Category: Science Authors: Sarah Boseley Tags: Coronavirus outbreak Medical research Aids and HIV Malaria Tuberculosis Health Science World news Source Type: news

We're desperate for a coronavirus cure, but at what cost to the human guinea pigs? | Kenan Malik
Big drugs companies have long favoured outsourcing clinical trials to poor countries with lax regulations to cut costs and maximise profit• Coronavirus latest updates• See all our coronavirus coverageLast week, in Oxford, the first volunteers in the first European human trial were injected with a potentialcoronavirus vaccine. At the same time, Pakistan ’s National Institute of Healthreceived an offer from the Chinese pharmaceutical firm Sinopharm International Corp to take part in a trial of another potential coronavirus vaccine.Related:Africa's Covid-19 research must be tailored to its realities – by...
Source: Guardian Unlimited Science - April 26, 2020 Category: Science Authors: Kenan Malik Tags: Coronavirus outbreak Medical research Pharmaceuticals industry Infectious diseases Aids and HIV Microbiology Business Science World news Source Type: news

8-Puff Dry-Powder Inhaler Wins Red Dot Product Design Award
Hovione Technology’s 8Shot Dry Powder Inhaler (DPI) has earned the Red Dot 2020 Product Design Award in the Healthcare Daily Living AIDS category. João Ventura Fernandes, PhD, director of technology development and licensing for Hovione Technology Ltd., told MD+DI that 8Shot “was developed to be the world’s first 8-dose, factory-filled dry powder inhaler device enabling effective and safe drug delivery to the lungs of a range of drugs expected to be developed and reach the market during the next years." It is targeted for "delivery of new pharma...
Source: MDDI - April 21, 2020 Category: Medical Devices Authors: Daphne Allen Tags: Design Source Type: news

Vaccines, Antibodies and Drug Libraries. The Possible COVID-19 Treatments Researchers Are Excited About
In early April, about four months after a new, highly infectious coronavirus was first identified in China, an international group of scientists reported encouraging results from a study of an experimental drug for treating the viral disease known as COVID-19. It was a small study, reported in the New England Journal of Medicine, but showed that remdesivir, an unapproved drug that was originally developed to fight Ebola, helped 68% of patients with severe breathing problems due to COVID-19 to improve; 60% of those who relied on a ventilator to breathe and took the drug were able to wean themselves off the machines after 18...
Source: TIME: Health - April 14, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

TB, HIV and COVID-19: Urgent Questions as Three Epidemics Collide
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post TB, HIV and COVID-19: Urgent Questions as Three Epidemics Collide appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - March 25, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Africa Headlines Health Source Type: news

Africa: Can There Be a Democratic Public Health? From HIV/Aids to COVID-19
[African Arguments] As we are re-learning with the coronavirus pandemic, the outbreak and global spread of a novel disease, which has neither vaccine nor proven cure, causes panic. More precisely, it causes political leaders and communities to resort to behaviours that intensify confusion and anxiety. Meanwhile, despite expert assurances to the contrary, public health 'best practices' are at best well-informed projections with the uncertainty factors on mute. At worst they can be superstitions. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - March 20, 2020 Category: Infectious Diseases Source Type: news

Coronavirus: Ten Reasons Why You Ought Not to Panic
This article is republished from The Conversation. Read the original article. The post Coronavirus: Ten Reasons Why You Ought Not to Panic appeared first on Inter Press Service. Excerpt: Ignacio López-Goñi is microbiologist and works in University of Navarra (Spain). The post Coronavirus: Ten Reasons Why You Ought Not to Panic appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - March 7, 2020 Category: International Medicine & Public Health Authors: Ignacio Lopez Goni Tags: Global Headlines Health Coronavirus Source Type: news

What Causes Neutropenia?
Discussion Neuropenia is defined as a neutrophil count
Source: PediatricEducation.org - March 2, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

NIH Slated for 7 percent Budget Cut
The President has proposed a $38.7 billion budget for the National Institutes of Health in fiscal year (FY) 2021. This translates to a $3 billion or 7 percent cut in the agency’s funding compared to FY 2020. The NIH budget request includes a $50 million initiative to use artificial intelligence (AI) to develop a better understanding of the causes of chronic diseases and to identify early treatments. This plan is in line with the Administration’s “Industries of the Future” effort, which supports using and developing AI across sectors. The budget would provide $50 million for the Childhood Cancer ...
Source: Public Policy Reports - February 18, 2020 Category: Biology Authors: AIBS Source Type: news

10 African Americans Who Have Shaped  Public Health
By Casey Bishopp, Communications officer, IntraHealth International ; Sabra Farquharson, Business development officer, IntraHealth InternationalFebruary 18, 2020We’re celebrating the legacies of ten African Americans in public health this month—shining a light on the invaluable contributions made by these scholars and health workers. According to themost recent report form the Health Resources and Services Administration, African Americans make up 11.6% of the US health workforce, and throughout American history have made invaluable contributions to greater public health in fields s...
Source: IntraHealth International - February 17, 2020 Category: International Medicine & Public Health Authors: cbishopp Source Type: news

Africa: The Search for an Effective HIV Vaccine Continues
[The Conversation Africa] An HIV vaccine trial that started in 2016 in South Africa was halted in February 2020. The study sponsors made the call after interim results showed that the vaccine, known as HVTN 702, did not prevent HIV. This result was disappointing, but the search for an effective HIV vaccine continues. Anatoli Kamali speaks to The Conversation Africa's Ina Skosana about other developments in the field. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - February 17, 2020 Category: Infectious Diseases Source Type: news

Kenya: Hopes Dashed as HIV Vaccine Trial is Cancelled
[Nation] When is was announced that the trials of HVTN 70, an experimental vaccine that could protect people against HIV, the virus that causes Aids, had been cancelled for non-efficacy, Ms Inviolata Mmbavi was disappointed. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - February 11, 2020 Category: Infectious Diseases Source Type: news

Non-Vaccine Oncogenic HPV Genotypes Persist in HPV-Vaccinated Women With HIV Non-Vaccine Oncogenic HPV Genotypes Persist in HPV-Vaccinated Women With HIV
Women living with HIV who received quadrivalent human papillomavirus (HPV) vaccination still face the risk of infection with non-vaccine oncogenic HPV genotypes, researchers from Canada report.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 8, 2020 Category: Pathology Tags: HIV/AIDS News Source Type: news

How Our Modern World Creates Outbreaks Like Coronavirus
“Everyone knows that pestilences have a way of recurring in the world,” observes Albert Camus in his novel The Plague. “Yet somehow we find it hard to believe in ones that crash down on our heads from a blue sky. There have been as many plagues as wars in history; yet plagues and wars always take people by surprise.” Camus was imagining a fictional outbreak of plague in 1948 in Oran, a port city in northwest Algeria. But at a time when the world is reeling from a very real microbial emergency sparked by the emergence of a novel coronavirus in Wuhan, central China, his observations are as pertinent a...
Source: TIME: Health - February 7, 2020 Category: Consumer Health News Authors: Mark Honigsbaum Tags: Uncategorized 2019-nCoV health ideas Source Type: news

Africa: Clinical Trial Halted, but Search for HIV Vaccine Continues
[UCT] The early abandonment of HIV vaccine study HVTN 702 (also known as Uhambo) in South Africa for failing to prevent infections is a huge setback in the quest to find an HIV vaccine. However, this will not deter scientists, said the University of Cape Town's (UCT) Professor Linda-Gail Bekker. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - February 5, 2020 Category: Infectious Diseases Source Type: news

Another H.I.V. Vaccine Fails a Trial, Disappointing Researchers
After more than 30 years of research, 1.7 million people are still infected each year with the virus that causes AIDS. (Source: NYT Health)
Source: NYT Health - February 4, 2020 Category: Consumer Health News Authors: Donald G. McNeil Jr. Tags: Acquired Immune Deficiency Syndrome Vaccination and Immunization National Institute for Allergy and Infectious Disease (NIAID) Fauci, Anthony S South Africa Source Type: news

ACIP Updates Recommendations for Adult Vaccines ACIP Updates Recommendations for Adult Vaccines
The ACIP's 2020 guidelines include updated instructions for nuanced shared clinical decision making in certain scenarios.News Alerts (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - February 3, 2020 Category: Infectious Diseases Tags: Infectious Diseases News Alert Source Type: news

HIV Vaccine Ineffective, Clinical Trial Halted
MONDAY, Feb. 3, 2020 -- A clinical trial for an HIV vaccine has been halted after it was concluded that it did not prevent infection with the AIDS-causing virus, the U.S. National Institute of Allergy and Infectious Diseases (NIAID) said Monday. The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 3, 2020 Category: Pharmaceuticals Source Type: news

HIV vaccine trial ends in 'deep disappointment'
A clinical trial for an HIV vaccine has been discontinued since the vaccine was not found to prevent infections of human immunodeficiency virus, the virus that causes AIDS. (Source: CNN.com - Health)
Source: CNN.com - Health - February 3, 2020 Category: Consumer Health News Source Type: news

Key HIV vaccine trial in South Africa ends because of poor results
Decision described as a ‘significant setback’ by International Aids SocietyThe latest trial of a vaccine against HIV has been halted because interim results show it is not working, the National Institutes of Health in the United States has announced.The end of the trial taking place in South Africa is a blow to the vaccine field and to Aids experts and advocates. As early as the mid-1980s, the US government was forecasting that Aids would be stopped by a vaccine. In 1997, the then-president Bill Clinton pledged money to an effort to find a vaccine within 10 years. But as the decades have passed, no effective va...
Source: Guardian Unlimited Science - February 3, 2020 Category: Science Authors: Sarah Boseley Health editor Tags: Aids and HIV Medical research South Africa US news Science World news Source Type: news

Scientists Hope New Tech Aids Coronavirus Vaccine Scientists Hope New Tech Aids Coronavirus Vaccine
Early trials in people suggest that such a vaccine can stimulate an immune response very well. But it has never been tried during an outbreak.WebMD Health News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 28, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news